Abstract: The present invention relates to compounds of formula (IA) wherein QA is QA1 or QA2 P is P1, heterocycyl or heterocyclyl substituted by one to five Z; and wherein A1, A2, A3, A4, G1, Z, R1, R2, R3 and R4 are as defined in claim 1; or a salt or N-oxide thereof. Furthermore, the present invention relates to processes and intermediates for preparing compounds of formula (IA), to insecticidal, acaricidal, nematicidal and molluscicidal compositions comprising the compounds of formula (IA) and to methods of using the compounds of formula (IA) to control insect, acarine, nematode and mollusc pests.

Abstract: The present invention provides compounds of formula I wherein Q is Q1 or Q2; A1, A2, A3 and A4 are independently of each other C—H, C—R7, or nitrogen; R1 is C1-C8haloalkyl; R2 is aryl or aryl substituted by one to five R11, or heteroaryl or heteroaryl substituted by one to five R11; and R3, R4, R5, R6 and R7 are as defined in the claims. The invention also provides methods of controlling insects, acarines, nematodes or molluscs which methods comprise applying to a pest, to a locus of a pest, or to a plant susceptible to attack by a pest an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I).

Abstract: The collapsible cleaning device includes a broom and a pan. The broom has a brush provided with bristles on the bottom surface thereof and secured by the top surface thereof to the end of a handle. The pan has a plate provided on at least one of the edges thereof with a wall projecting from the top face as well as a gripper secured to the wall. The brush is hinged to pass from a retracted position extending along the handle to an extended position extending orthogonally relative to handle, and vice versa.

Abstract: The invention concerns a method for making an abrasion resistant steel plate having a chemical composition comprising: 0.35%?C?0.8%, 0%?Si?2%, 0%?Al?2%, 0.35%?Si+Al?2%, 0%?Mn?2.5%, 0%?Ni?5%, 0%?Cr?5%, 0%?Mo?0.50%, 0%?W?1.00%, 0.1%?Mo+W/2?0.50%, 0%?B?0.02%, 0%?Ti?2%, 0%?Zr?4%, 0.05%?Ti+Zr/2?2%, 0%?S?0.15%, N<0.03%; optionally from 0% to 1.5% of Cu; optionally Nb, Ta or V with Nb/2+Ta/4+V?0.5%; optionally less than 0.1% of Se, Te, Ca, Bi or Pb; the rest being iron and impurities; the composition satisfying: 0.1%?C*=C?Ti/4?Zr/8+7×N/8?0.55% and 1.05×Mn+0.54×Ni+0.50×Cr+0.3×(Mo+W/2)1/2+K>1.8, with K=0.5 if B?0.0005% and K=0 if B<0.0005% and Ti+Zr/2?7×N/2?0.05%; hardening after austenitization while cooling at a speed>0.5° C./s between a temperature>AC3 and ranging between T=800?270×C*?90×Mn?37×Ni?70×Cr?83×(Mo+W/2) and T?50° C.; then at a core speed Vr<115×ep?1.7 between T and 100° C., (ep=plate thickness in mm); cooling down to room temperature. The invention also concerns the resulting plate.

Abstract: The invention relates to a nuclear reactor primary circuit comprising a primary pipeline (30), which defines an internal volume (32) and in which a primary nuclear reactor coolant downwardly runs, an additional pipeline (26) which is branched to the primary pipeline (30) and defines an internal volume communicating with the internal volume (32) of the primary pipeline (30) and a cuff (36) whose first end (50) is connected to the additional pipeline (26) and the second free end (52) is positioned in the internal volume (32) of the primary pipeline (30). According to said invention, the second end (52) is delimited by a free peripherial edge (53) comprising at least one upstream and downstream sections (56, 58) which are oriented towards the upstream, wherein the upstream section (56) penetrates into the internal volume (32) deeper from the primary pipeline (30) than the downstream section (58).

Abstract: The invention provides an article having a mesoporous silicate matrix, such as a particle, having one or more pores; and one or more releasable caps obstructing one or more of the pores for delivery of one or more agents to plant cells or other chlorophyll containing cells, or fungi.

Abstract: The present invention relates to the use of Ang-(1-7) and/or Ang-(1-7) receptor agonist and/or Ang (1-7) analogue in treating/restoring erectile dysfunction.

Abstract: The present invention relates to plant genes involved in positive regulation of resistance to fungal pathogens and uses thereof. More particularly, the present invention relates to plants which overexpress WAK91 gene, or an ortholog thereof, and having increased resistance to fungal pathogens. The invention also relates to methods for producing modified plants having increased or improved fungal disease and pathogen resistance. Furthermore, the invention relates to methods of screening and identifying molecules that induce WAK91 gene expression.

Abstract: Systems and methods for delivering media over a network are provided. Multiple media assets are stored on a server, as well as a representation for at least one media asset. The representation of a media asset is delivered to a client. A client user request based on selection of a representation is received, and the represented media asset is delivered from the server in response to the client user request.

Abstract: An ACARS message communications system including at least one on-board piece of equipment harbouring an application adapted for transmitting and/or receiving ACARS messages, and a router adapted for routing, via a plurality of subnetworks, ACARS messages from and/or to the application. The piece of equipment and the router are connected to an AFDX network and the application is adapted for dynamic registration at the router, via the network, the router only routing the messages if the application is actually registered thereat.

Abstract: A system for routing ACARS messages towards a plurality of transmission media, configured to be loaded onboard an aircraft, including: a database including a plurality of routing profiles, each profile being formed by a list indicating a rank of preference for each transmission medium, and a selection mechanism extracting, from an ACARS message sending request, a routing profile identifier, and selecting in the routing profile stored in the database, corresponding to the identifier, a transmission medium, according to its rank of preference, the thereby selected transmission medium then being used for transmitting the message.

Abstract: The invention relates to the use of at least one compound of the formula (I), in which R and R3 are particularly a hydrogen atom, R1 is particularly a hydrogen atom or a methyl, ethyl or isobutyl mi group, R4, R5, R6 and R7 are independently a hydrogen atony, an alkoxyl group with 1 to 7 carbon atoms or a halogen atom, R2 is a hydrogen atom, an O? group or an OH group, B is an N-GP1 or NRc, group, GP1 being a Boc or Cbz group, and Rc is a hydrogen atom or a methyl or t-butyl group, for preparing a drug for treating conditions associated with bacterial infections, in particular for treating bacterial diseases.

Abstract: Inclusion compounds consisting of certain Angiotensin II AT1 receptors antagonist and cyclodextrins are described. These inclusion compounds are useful in the treatment of hypertension.

Abstract: A method for producing an aortic or mitral heart valve prosthesis and the resulting aortic or mitral heart valve. The method is characterized in that it essentially consists in producing the prosthesis by shaping a textile material. The invention is more particularly applicable in the field of medicine, in particular repair surgery, and especially in heart surgery, more particularly heart prostheses.

Abstract: The invention concerns a method for making an abrasion resistant steel plate having a chemical composition comprising: 0.1%?C<0.23%; 0%?Si?2%; 0%?Al?2%; 0.5%?Si+Al?2%; 0%?Mn?2.5%; 0%?Ni?5%; 0%?Cr?5%; 0%?Mo?1%; 0%?W?2%; 0.05%?Mo+W/2?1%; 0%?Cu?1.5%; 0%?B?0.02%; 0%?Ti?0.67%; 0%?Zr?1.34%; 0.05%<Ti+Zr/2?0.67%; 0%?S?0.15%; N<0.03%, optionally 0% to 1.5% of Cu; optionally Nb, Ta and V such that Nb/2+Ta/4+V?0.5%; optionally Se, Te, Ca, Bi, Pb contents ?0.1%; the rest being iron impurities. Additionally: 0.095%?C*=C?Ti/4?Zr/8+7×N/8, Ti+Zr/2?7×N/2?0.05% and 1.05×Mn+0.54×Ni+0.50×Cr+0.3×(Mo+W/2)1/2+K>1.8, with K=1 if B?0.0005% and K=0 if B<0.0005%. After austenitization, the method consists in: cooling at a speed >0.5° C./s between a temperature between AC3 and T=800?270×C*?90×Mn?37×Ni?70×Cr?83×(Mo+W/2) and about T?50° C.; then cooling at a speed 0.1<Vr<1150×ep?1.7 between T and 100° C., (ep=plate thickness in mm); cooling down to room temperature and optionally planishing.

Abstract: The invention relates to a valve endoprosthesis, characterised in that it substantially comprises an extensible stent or frame (1) made of several parts, i.e. an upper cylinder (11), a lower bearing portion (21) having the shape of a truncated cone and a maximum diameter higher than that of the aortic ring and decreasing down to the diameter of the extensible stent or frame (1) in the direction of the proximal end, and arches (31), the upper cylinder (11) being connected to the lower bearing portion (21) via mounts (41) and by a valve (2) connected to said stent (1) by stitches, staples or clips. The invention can particularly be used in the field of medicine, in particular in plastic surgery, and particularly in cardiac surgery, in particular for cardiac prostheses.

Abstract: Preparation of AT1 receptors antagonists formulations using the cyclodextrins, their derivatives and/or biodegradable polymers for the treatment of arterial hypertension, other cardiovascular disease and their complications. Until now, no applications using the AT11 receptor antagonists and cyclodextrins or derivatives and/or biodegradable polymers for the treatment of arterial hypertension, other cardiovascular diseases and their complications, was found in the technical state of art. The present invention is characterized by the combination of two different technologies: one is the molecular encapsulation of AT11 receptor antagonists in cyclodextrins and the other is the microencapsulation in biodegradable polymers. It also comprises the increase of the effectiveness of the AT11 receptor antagonists as well as an increase in their bio-availability.

Abstract: The medical therapy device includes at least one picture-providing locating device, a treatment device, a patient rest, means for the motorized positioning of at least the treatment device relative to the patient rest, means for control of the therapy device, and a display and operating device. The treatment center of the treatment device may be represented on the display in at least one picture of the locating device on the display, and operating elements are provided, with which the positioning in coordinates of the locating device may be controlled.

Abstract: Preparation of AT1 receptors antagonists formulations using the cyclodextrins, their derivatives and/or biodegradable polymers for the treatment of arterial hypertension, other cardiovascular disease and their complications. Until now, no applications using the AT11 receptor antagonists and cyclodextrins or derivatives and/or biodegradable polymers for the treatment of arterial hypertension, other cardiovascular diseases and their complications, was found in the technical state of art. The present invention is characterized by the combination of two different technologies: one is the molecular encapsulation of AT11 receptor antagonists in cyclodextrins and the other is the microencapsulation in biodegradable polymers. It also comprises the increase of the effectiveness of the AT11 receptor antagonists as well as an increase in their bio-availability.

Abstract: A system for routing ACARS messages towards a plurality of transmission media, configured to be loaded onboard an aircraft, including: a database including a plurality of routing profiles, each profile being formed by a list indicating a rank of preference for each transmission medium, and a selection mechanism extracting, from an ACARS message sending request, a routing profile identifier, and selecting in the routing profile stored in the database, corresponding to the identifier, a transmission medium, according to its rank of preference, the thereby selected transmission medium then being used for transmitting the message.